WINSTON-SALEM, N.C., June 6 /PRNewswire-FirstCall/ -- Targacept, Inc. today announced that J. Donald deBethizy, Ph.D., President and Chief Executive Officer, is scheduled to present at the Pacific Growth Equities 2006 Life Sciences Growth Conference being held June 12-14, 2006 at The Mark Hopkins Inter-Continental Hotel in San Francisco. Dr. deBethizy will present an overview of Targacept and its product development programs on Tuesday, June 13 at 8:30 a.m. Pacific Time.
(Logo: http://www.newscom.com/cgi-bin/prnh/20010517/CHTH002LOGO )
The Targacept presentation will be webcast and accessible from the Investor Relations section of the Company’s website, www.targacept.com. The webcast will also be available for replay on the Company’s website following the conference until July 14, 2006. To ensure a timely connection to the webcast, it is recommended that users register at least 15 minutes prior to the scheduled start time.
About Targacept
Targacept is a biopharmaceutical company engaged in the design, discovery and development of a new class of drugs to treat multiple diseases and disorders of the central nervous system by selectively targeting neuronal nicotinic receptors, or NNRs. Targacept is located in Winston-Salem, North Carolina.
Photo: http://www.newscom.com/cgi-bin/prnh/20010517/CHTH002LOGOPRN Photo Desk, photodesk@prnewswire.comTargacept, Inc.
CONTACT: Alan Musso, VP and CFO of Targacept, Inc., +1-336-480-2186, oralan.musso@targacept.com, or Michelle Linn of Linnden Communications,+1-508-419-1555, or linnmich@comcast.net
Web site: http://www.targacept.com/
